Cutler Group’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | $2K | Sell |
1,300
-176,000
| -99% | -$4.88M | ﹤0.01% | 1884 |
|
|
2023
Q4 | $76K | Buy |
177,300
+38,700
| +28% | +$1.17M | 0.01% | 1195 |
|
|
2023
Q3 | $45K | Buy |
138,600
+17,800
| +15% | +$629K | ﹤0.01% | 1562 |
|
|
2023
Q2 | $11K | Buy |
120,800
+69,600
| +136% | +$2.71M | ﹤0.01% | 2205 |
|
|
2023
Q1 | $21K | Sell |
51,200
-238,900
| -82% | -$10.3M | ﹤0.01% | 1899 |
|
|
2022
Q4 | $274K | Buy |
290,100
+46,700
| +19% | +$2.24M | 0.02% | 652 |
|
|
2022
Q3 | $99K | Sell |
243,400
-52,900
| -18% | -$2.57M | 0.01% | 1396 |
|
|
2022
Q2 | $653K | Sell |
296,300
-346,400
| -54% | -$17.7M | 0.05% | 451 |
|
|
2022
Q1 | $905K | Sell |
642,700
-268,200
| -29% | -$13.9M | 0.05% | 419 |
|
|
2021
Q4 | $5.1M | Sell |
910,900
-364,500
| -29% | -$18.1M | 0.21% | 90 |
|
|
2021
Q3 | $805K | Buy |
1,275,400
+1,020,800
| +401% | +$45.2M | 0.04% | 555 |
|
|
2021
Q2 | $371K | Sell |
254,600
-61,600
| -19% | -$2.4M | 0.02% | 916 |
|
|
2021
Q1 | $150K | Sell |
316,200
-337,200
| -52% | -$12M | 0.01% | 1464 |
|
|
2020
Q4 | $337K | Buy |
653,400
+383,154
| +142% | +$14.1M | 0.02% | 814 |
|
|
2020
Q3 | $125K | Buy |
270,246
+68,405
| +34% | +$2.4M | 0.01% | 1184 |
|
|
2020
Q2 | $59K | Buy |
201,841
+90,222
| +81% | +$3.07M | ﹤0.01% | 1639 |
|
|
2020
Q1 | $62K | Buy |
+111,619
| New | +$3.8M | ﹤0.01% | 1603 |
|
|
2019
Q4 | – | Sell |
-4,638
| Closed | -$1K | – | 4450 |
|
|
2019
Q3 | $1K | Buy |
+4,638
| New | +$169K | ﹤0.01% | 3796 |
|
|
2019
Q1 | – | Sell |
-21,080
| Closed | -$40K | – | 4575 |
|
|
2018
Q4 | $40K | Sell |
21,080
-182,553
| -90% | -$7.58M | ﹤0.01% | 1625 |
|
|
2018
Q3 | $806K | Buy |
203,633
+140,393
| +222% | +$5.4M | 0.06% | 328 |
|
|
2018
Q2 | $16K | Sell |
63,240
-54,808
| -46% | -$1.87M | ﹤0.01% | 2349 |
|
|
2018
Q1 | $5K | Buy |
118,048
+26,245
| +29% | +$902K | ﹤0.01% | 3298 |
|
|
2017
Q4 | $13K | Buy |
91,803
+1,475
| +2% | +$50.3K | ﹤0.01% | 2929 |
|
|
2017
Q3 | $45K | Sell |
90,328
-111,091
| -55% | -$3.57M | ﹤0.01% | 2336 |
|
|
2017
Q2 | $109K | Sell |
201,419
-55,335
| -22% | -$1.75M | ﹤0.01% | 1785 |
|
|
2017
Q1 | $174K | Sell |
256,754
-200,682
| -44% | -$6.33M | 0.01% | 1291 |
|
|
2016
Q4 | $172K | Buy |
457,436
+316
| +0.1% | +$9.65K | 0.01% | 1420 |
|
|
2016
Q3 | $407K | Buy |
457,120
+43,636
| +11% | +$1.46M | 0.02% | 714 |
|
|
2016
Q2 | $911K | Buy |
413,484
+172,750
| +72% | +$5.51M | 0.05% | 316 |
|
|
2016
Q1 | $212K | Sell |
240,734
-29,617
| -11% | -$846K | 0.01% | 980 |
|
|
2015
Q4 | $432K | Buy |
+270,351
| New | +$8.5M | 0.02% | 697 |
|
Other funds holding PFE
Cutler Group's PFE Position: Q1 2024 in Review
Cutler Group reduced its Pfizer (PFE) stake by 92% in Q1 2024, selling an estimated $3.36M and leaving 10,075 shares worth $279K. The position accounts for 0.09% of the portfolio, ranked #216.
Cutler Group first reported a position in PFE in Q4 2015 and has held it in 33 quarters since. The position peaked at $10.8M in Q1 2022. 2,874 funds tracked by Wall St. Rank hold PFE as of Q1 2024.
- Cutler Group held 10,075 shares of Pfizer worth $279K as of Q1 2024.
- Cutler Group sold 120,937 Pfizer shares in Q1 2024, an estimated $3.36M.
- Pfizer made up 0.09% of Cutler Group's portfolio in Q1 2024, its #216 holding.
- Cutler Group first reported a position in Pfizer in Q4 2015 and has held it in 33 quarters since.
- Cutler Group's Pfizer position peaked at $10.8M in Q1 2022.
- 2,874 funds tracked by Wall St. Rank held Pfizer as of Q1 2024.
Based on Cutler Group's 13F filing for Q1 2024, filed 19 Apr 2024.